Orion develops and produces proprietary drugs for both humans and animals. The Proprietary Products division is responsible for Orion’s proprietary drugs for humans. Proprietary Products is the largest division of Orion's Pharmaceuticals business.   

Net Sales 2010:  EUR 370.9 million

Seven own proprietary drugs
Despite the tougher challenges, Orion has launched many successful products. The company has engaged in systematic research since the 1980s and has introduced seven proprietary drugs to the global market. Three of these are for veterinary use. Orion’s proprietary product range is composed of Orion’s own proprietary drugs and in-licensed products. 

The Proprietary Products division is composed of three core therapy areas:

The research and development of proprietary drugs is a long process that can take up to 15 years and involves many risks. To become successful, a new proprietary drug must first prove its clinical superiority in the market. In addition, introduction of new pharmaceutical discoveries requires more and more intense marketing efforts.

Read more about human prescription medicines here